Deletion of Lpcat3 ameliorates insulin resistance and blunts lipogenesis in both diet‐ and obesity‐induced models, thus alleviating the deleterious effects of insulin resistance on both glucose and lipid metabolism. The gene discussed is LPCAT3; the disease is obesity due to melanocortin 4 receptor deficiency.